Back to Speakers
Dr Anna Lavelle was appointed as Chair of the Medicines Australia Board in 2018, following on from roles as Deputy Chair and Independent Director. Dr Lavelle is an experienced Non-Executive Director, serving for nearly 30 years on the boards of not for profit, government and for profit entities including Chair Avatar Brokers, Cyban Pty Ltd, Hemideina Ltd and the Member Health Innovation Advisory Committee. From 2005 to 2016, she was the CEO of AusBiotech, the national industry association for the biotechnology, pharmaceutical and medical devices sectors. Dr Lavelle is an ATSE Fellow and has a PhD in Genetics.
Chair, Medicines Australia
Dr Anna Lavelle
Proudly sponsored by:
The Panel: State of the Industry
Friday 20 March, 8:33am - 9:25am
SPONSOR AND TRADE
(c) 2021 APP Conference 2022. All Rights Reserved.
The Pharmacy Guild of Australia
07 3831 9246
07 3831 3788
© 2022 APP Conference. All Rights Reserved.
The 2022 Australian Pharmacy Professional Conference is proudly sponsored by:
TERMS AND CONDITIONS
APP Sand 1
APP OCEAN 3
APP OCEAN 2